Menü Kapat

Review Article

Pharmacological treatment of obesity in clinical practice

Omercan Topaloglu, Ibrahim Sahin



Anti-obesity medications may be considered in the subjects with BMI ≥30 kg/m2, or with BMI 27-29.9 kg/m2 and weight-related comorbidities, whom weight reduction is not achieved via lifestyle modifications alone. If weight loss is inadequate (

Key words: Obesity, pharmacological treatment, obesity treatment, liraglutide, orlistat

Med-Science. 2021; 10(2): 651-7

Medicine Science Vol:10 Issue:2 Year:2021 PP:272–669
Posted in Vol: 10 Issue: 2 Year: 2021 June pp: 272–669

Related Posts

%d blogcu bunu beğendi: